SPC Dec 15, 2024 Day 4-8 Severe Weather Outlook
Day 4-8 Outlook Day 4-8 Convective Outlook NWS Storm Prediction Center Norman OK 0312 AM CST Sun Dec 15 2024 Valid 181200Z - 231200Z ...DISCUSSION... A surface cold front will move south and east across the eastern and southeastern U.S. on Day 4/Wed, moving offshore the Gulf and Atlantic coasts by early Day 5/Thu. Showers and thunderstorms are possible near the cold front across parts of the Southeast and Mid-Atlantic vicinity on Day 4/Wed. However, weak instability and only modest vertical shear is expected to limit severe thunderstorm potential. After Day 4/Wed, a mean upper level trough will persist over
SPC Dec 15, 2024 0830 UTC Day 3 Severe Thunderstorm Outlook
SPC 0830Z Day 3 Outlook Day 3 Convective Outlook NWS Storm Prediction Center Norman OK 0159 AM CST Sun Dec 15 2024 Valid 171200Z - 181200Z ...NO SEVERE THUNDERSTORM AREAS FORECAST... ...SUMMARY... Severe thunderstorms are not expected on Tuesday. ...Synopsis... Westerly flow across much of the CONUS will become more amplified as a shortwave trough deepens and develops east from the northern/central Rockies to the Upper Midwest vicinity on Tuesday. The southwest extent of the upper trough will lag, remaining over the Southern Rockies/Four Corners vicinity. Stronger mid/upper level southwesterly flow associated with the deepening trough will extend from OK/KS
FEMA Provides $15 Million to the Minnesota Department of Health
FEMA Provides $15 Million to the Minnesota Department of Health CHICAGO – The U.S. Department of Homeland Security’s Federal Emergency Management Agency (FEMA) and the Minnesota Department of Public Safety Homeland Security and Emergency Management division (DPS-HSEM) announced today that $15 million in federal funding has been made available to the Minnesota Department of Health for costs related to the state’s COVID-19 vaccine distribution plan under the federal disaster declaration of April 7, 2020. This funding is an advance payment to the Minnesota Department of Health for eligible reimbursable costs to distribute and administer available COVID-19 vaccines through the establishment